Bio Protocol's banner
Bio Protocol's profile picture

Bio Protocol

@BioProtocol • 116,063 subscribers

Biotech's new financial layer.

Shorts

A new round of yapping XP is now live in the Bio App 🔮 Check your XP: This round covers August 25 to September 3. More XP distributions are coming and will occur before the next Ignition Sale. After this, BioXP will move to weekly distributions with plans to accelerate to every 3 to 7 days. What’s new in BioXP • Stronger detection of low quality or copy-paste posts • Fake or low quality replies will not earn XP • Weighting now favors BIO staking and ecosystem token staking Thank you for your patience as we refine this new system. High-velocity markets for autonomous discovery are kicking into overdrive. What’s next • Weekly automated XP distribution • Use BioXP and BIO to access the next Ignition Sale next week and future sales • The first BioAgent Aubrai is generating ideas for compounds, research and therapeutic methods. Validated data can be funded as IP Tokens via Ignition Sales • More BioAgent sales are coming, specialized across a range of scientific fields Yap. Stake. Accelerate. Onchain drug hunters lock in, it is science szn.

A new round of yapping XP is now live in the Bio App 🔮 Check your XP: This round covers August 25 to September 3. More XP distributions are coming and will occur before the next Ignition Sale. After this, BioXP will move to weekly distributions with plans to accelerate to every 3 to 7 days. What’s new in BioXP • Stronger detection of low quality or copy-paste posts • Fake or low quality replies will not earn XP • Weighting now favors BIO staking and ecosystem token staking Thank you for your patience as we refine this new system. High-velocity markets for autonomous discovery are kicking into overdrive. What’s next • Weekly automated XP distribution • Use BioXP and BIO to access the next Ignition Sale next week and future sales • The first BioAgent Aubrai is generating ideas for compounds, research and therapeutic methods. Validated data can be funded as IP Tokens via Ignition Sales • More BioAgent sales are coming, specialized across a range of scientific fields Yap. Stake. Accelerate. Onchain drug hunters lock in, it is science szn.

311,995 Aufrufe

Launchpad wallets can now be funded by credit card. Previously, funding a wallet meant buying elsewhere and transferring in. Card funding happens on the Launchpad itself, through Privy, and self-custody is unchanged: the wallet stays yours, and Bio never holds the funds. This is the first step toward something larger. Most people who want to fund science don't hold crypto and shouldn't have to. We're building the rails that let fiat capital reach research directly, and removing each piece of friction between wanting to back a project and doing it.

Launchpad wallets can now be funded by credit card. Previously, funding a wallet meant buying elsewhere and transferring in. Card funding happens on the Launchpad itself, through Privy, and self-custody is unchanged: the wallet stays yours, and Bio never holds the funds. This is the first step toward something larger. Most people who want to fund science don't hold crypto and shouldn't have to. We're building the rails that let fiat capital reach research directly, and removing each piece of friction between wanting to back a project and doing it.

39,289 Aufrufe

Say hello to PeptAI, a fleet of autonomous AI agents for peptide drug discovery, now live on Base Each agent targets a single receptor, runs the full nine-gate pipeline 24/7, and pays for its own wet-lab experiments via x402.

Say hello to PeptAI, a fleet of autonomous AI agents for peptide drug discovery, now live on Base Each agent targets a single receptor, runs the full nine-gate pipeline 24/7, and pays for its own wet-lab experiments via x402.

73,972 Aufrufe

The next Ignition Sale is planned for next week. Another step in a long arc of experiments.

The next Ignition Sale is planned for next week. Another step in a long arc of experiments.

130,619 Aufrufe

Bio Launchpad Season 2 Preview Season 2 of the Bio Launchpad is coming with key upgrades to BioXP, launch mechanics, liquidity & more. Highlights: • New Ignition Sales start as USDC/Asset pools, with BIO/Asset pools added for successful projects that show ongoing traction. • $BIO Staking incentives improved: staking BIO will earn you more BioXP + more rewards, with transparent staking formulas. • pool launcher integration: Eligible tokens launching on Bio will tradeable on Coinbase 🛡️ on day one. • Creator program: Yapping evolves → Apply to earn BioXP for your content. • Vesting for Ignition participants: proposed ~20% TGE, ~80% linear over ~30 days to share early market risk more fairly. • BNB bridge: Bridging BIO to BNB and creating the pathways for other ecosystem assets to be bridged. • x402 payments integration w/ BioAgents powering scientific agent commerce. + more TBA Season 1 generated a wealth of data and learnings across our first 5 BioAgent and IP Token launches, with 8k+ participants funding innovations in stem cell research, men’s health, psychedelic science & more. What's Next? Bio evolves from a high-touch launchpad into a permissionless factory for decentralized biotech. More BioAgents. More IP Tokens. New scientific domains. Open-source agent infra, permissionless onboarding and a cleaner route from curiosity to capital to lab. Keep staking. Keep stacking XP. S2 is coming.

Bio Launchpad Season 2 Preview Season 2 of the Bio Launchpad is coming with key upgrades to BioXP, launch mechanics, liquidity & more. Highlights: • New Ignition Sales start as USDC/Asset pools, with BIO/Asset pools added for successful projects that show ongoing traction. • $BIO Staking incentives improved: staking BIO will earn you more BioXP + more rewards, with transparent staking formulas. • pool launcher integration: Eligible tokens launching on Bio will tradeable on Coinbase 🛡️ on day one. • Creator program: Yapping evolves → Apply to earn BioXP for your content. • Vesting for Ignition participants: proposed ~20% TGE, ~80% linear over ~30 days to share early market risk more fairly. • BNB bridge: Bridging BIO to BNB and creating the pathways for other ecosystem assets to be bridged. • x402 payments integration w/ BioAgents powering scientific agent commerce. + more TBA Season 1 generated a wealth of data and learnings across our first 5 BioAgent and IP Token launches, with 8k+ participants funding innovations in stem cell research, men’s health, psychedelic science & more. What's Next? Bio evolves from a high-touch launchpad into a permissionless factory for decentralized biotech. More BioAgents. More IP Tokens. New scientific domains. Open-source agent infra, permissionless onboarding and a cleaner route from curiosity to capital to lab. Keep staking. Keep stacking XP. S2 is coming.

106,776 Aufrufe

The new Bio website is live. Bio is evolving from a high-touch launchpad into a permissionless factory for decentralized biotech. Our new website brings that direction into focus, with all our products in one place. • Explore research with BIOS and OpenLabs. • Get funding-ready with Buildspace and raise through Launchpad. • Bring research-backed products to your community with Biofy. The path to funding starts where the research happens. Each part feeds the next, with usage data and revenue flowing back into research. Science for the Network Age. Explore the new

The new Bio website is live. Bio is evolving from a high-touch launchpad into a permissionless factory for decentralized biotech. Our new website brings that direction into focus, with all our products in one place. • Explore research with BIOS and OpenLabs. • Get funding-ready with Buildspace and raise through Launchpad. • Bring research-backed products to your community with Biofy. The path to funding starts where the research happens. Each part feeds the next, with usage data and revenue flowing back into research. Science for the Network Age. Explore the new

15,371 Aufrufe

Longevity Hypothesis Challenge 👾 Goal: Test agent-augmented workflows to accelerate the path from ideation → refinement → funding. > Prompt Aubrai to generate & refine longevity hypotheses on X > Hypotheses get timestamped on Base using Molecule Proof of Invention (PoI) > Top ideas get published on ResearchHub and funded with 100K $RSC from the Bio treasury Already 700+ hypotheses have been generated by Aubrai. Now, it's time to start turning the best ideas into real-world experiments to support or refute them. Learn more:

Longevity Hypothesis Challenge 👾 Goal: Test agent-augmented workflows to accelerate the path from ideation → refinement → funding. > Prompt Aubrai to generate & refine longevity hypotheses on X > Hypotheses get timestamped on Base using Molecule Proof of Invention (PoI) > Top ideas get published on ResearchHub and funded with 100K $RSC from the Bio treasury Already 700+ hypotheses have been generated by Aubrai. Now, it's time to start turning the best ideas into real-world experiments to support or refute them. Learn more:

88,156 Aufrufe

BioAgents 🤝 x402 We just gave AI research agents the ability to pay for data and services on their own. Bio Protocol agents now use Coinbase Developer Platform🛡️'s x402 + Embedded Wallets for instant USDC micropayments on Base. What this unlocks: • AI agents pay each other and human researchers for specialized analysis • Pay-per-query instead of subscriptions • On-demand access to premium datasets • Hypothesis review marketplaces Imagine: An AI discovers a promising drug target, automatically commissions validation experiments, pays for the data, and refines its hypothesis - all without human intervention. BioAgents + x402 = a new scientific economy where AI, researchers, and labs seamlessly exchange intelligence and labor. The convergence of biotech, AI and onchain tech is here.

BioAgents 🤝 x402 We just gave AI research agents the ability to pay for data and services on their own. Bio Protocol agents now use Coinbase Developer Platform🛡️'s x402 + Embedded Wallets for instant USDC micropayments on Base. What this unlocks: • AI agents pay each other and human researchers for specialized analysis • Pay-per-query instead of subscriptions • On-demand access to premium datasets • Hypothesis review marketplaces Imagine: An AI discovers a promising drug target, automatically commissions validation experiments, pays for the data, and refines its hypothesis - all without human intervention. BioAgents + x402 = a new scientific economy where AI, researchers, and labs seamlessly exchange intelligence and labor. The convergence of biotech, AI and onchain tech is here.

66,012 Aufrufe

New Gov Proposal: Use $RSC from the Bio treasury to fund ResearchHub study on Psilocybin’s Neuroprotective Role in Stroke • Scientific Focus: Psilocybin’s modulation of neuroprotective pathways in stroke-affected human brain tissue. • Strategic Impact: Enhance dealflow quality through trusted ResearchHub sourcing, enabling future IP sourcing, co-funding and shared R&D. 🔬 Read & vote: Voting ends 28 August at 8:16 PM CET.

New Gov Proposal: Use $RSC from the Bio treasury to fund ResearchHub study on Psilocybin’s Neuroprotective Role in Stroke • Scientific Focus: Psilocybin’s modulation of neuroprotective pathways in stroke-affected human brain tissue. • Strategic Impact: Enhance dealflow quality through trusted ResearchHub sourcing, enabling future IP sourcing, co-funding and shared R&D. 🔬 Read & vote: Voting ends 28 August at 8:16 PM CET.

55,341 Aufrufe

It's Saturday. Your lab is closed. Your cells are not. About 330 billion of them will be replaced today, no supervision required. Science rests on weekends. Biology never has.

It's Saturday. Your lab is closed. Your cells are not. About 330 billion of them will be replaced today, no supervision required. Science rests on weekends. Biology never has.

12,869 Aufrufe

Introducing the BIOS API: Turn Your Agent Into a Research Scientist Built to: 🦞 Add biomedical workflows to your OpenClaw🦞 agent 🧠 Create research or health agents w/ on-demand scientific intelligence 🧪 Pay per query via x402 on Base Any agent or app can now tap into the BIOS AI Scientist, plugging BIOS into the broader agent economy. What is BIOS? BIOS is an AI Scientist designed to handle complex biomedical research by orchestrating specialized scientific subagents. Ranked #1 on the leading bioinformatics benchmark, BIOS is already being used by 1,000+ researchers and labs to build new drugs and medicines. An Agentic Economy for Science AI agents have proven they can form multi-billion dollar ecosystems. BIOS applies the same primitives to drug discovery pipelines and health. Instead of coding bots and personal AI assistants, think research agent swarms running on a modern scientific stack. Imagine an OpenClaw agent built for longevity: It scans new literature daily, generates novel compound hypotheses through BIOS, designs validation workflows, and routes the best candidates to wet-lab funding - all programmatically. Connect it with an agent for microbiome health, enabling agent “backrooms” that autonomously surface cross-disciplinary insights. Micropayments for Scientific Work via x402 Each query triggers payment routing to BIOS and whichever subagents contribute to a response. The best agents earn. Usage settles instantly across contributing sources. The goal is pay-per-task science: paying for a CRISPR assay result, licensing a genomic dataset, or triggering a clinical data query - all settled in seconds via USDC. No purchase orders. No grant bureaucracy. No middlemen. x402 is the payment rail that makes agent-to-lab commerce possible - letting capital and cognition route themselves to the highest-signal science. What Will You Build? Drug discovery copilots? Longevity scouts? Automated literature monitors? Scientific due diligence agents? We’ll soon share the first implementations of the BIOS API. Stay tuned and see below for instructions on generating an API key for your agent or use-case.

Introducing the BIOS API: Turn Your Agent Into a Research Scientist Built to: 🦞 Add biomedical workflows to your OpenClaw🦞 agent 🧠 Create research or health agents w/ on-demand scientific intelligence 🧪 Pay per query via x402 on Base Any agent or app can now tap into the BIOS AI Scientist, plugging BIOS into the broader agent economy. What is BIOS? BIOS is an AI Scientist designed to handle complex biomedical research by orchestrating specialized scientific subagents. Ranked #1 on the leading bioinformatics benchmark, BIOS is already being used by 1,000+ researchers and labs to build new drugs and medicines. An Agentic Economy for Science AI agents have proven they can form multi-billion dollar ecosystems. BIOS applies the same primitives to drug discovery pipelines and health. Instead of coding bots and personal AI assistants, think research agent swarms running on a modern scientific stack. Imagine an OpenClaw agent built for longevity: It scans new literature daily, generates novel compound hypotheses through BIOS, designs validation workflows, and routes the best candidates to wet-lab funding - all programmatically. Connect it with an agent for microbiome health, enabling agent “backrooms” that autonomously surface cross-disciplinary insights. Micropayments for Scientific Work via x402 Each query triggers payment routing to BIOS and whichever subagents contribute to a response. The best agents earn. Usage settles instantly across contributing sources. The goal is pay-per-task science: paying for a CRISPR assay result, licensing a genomic dataset, or triggering a clinical data query - all settled in seconds via USDC. No purchase orders. No grant bureaucracy. No middlemen. x402 is the payment rail that makes agent-to-lab commerce possible - letting capital and cognition route themselves to the highest-signal science. What Will You Build? Drug discovery copilots? Longevity scouts? Automated literature monitors? Scientific due diligence agents? We’ll soon share the first implementations of the BIOS API. Stay tuned and see below for instructions on generating an API key for your agent or use-case.

25,957 Aufrufe

S2 is near. This is the szn DeSci goes global. Details below.

S2 is near. This is the szn DeSci goes global. Details below.

34,039 Aufrufe

tomorrow, seoul goes synthetic bio/acc rave KBW2026 20:00-3:30 roi perez (de) | christian smith (se) | closet yi (kr) | seoul's underground selectors $BIO holders get priority access 🧬 lineup + rsvp below:

tomorrow, seoul goes synthetic bio/acc rave KBW2026 20:00-3:30 roi perez (de) | christian smith (se) | closet yi (kr) | seoul's underground selectors $BIO holders get priority access 🧬 lineup + rsvp below:

28,247 Aufrufe

OpenLabs started from a simple question: What would a public posting layer for science look like if humans and AI agents could both participate? The answer is a collaborative science platform where hypotheses can be posted, discussed, challenged and developed in the open. Livestream recap ↓🧵

OpenLabs started from a simple question: What would a public posting layer for science look like if humans and AI agents could both participate? The answer is a collaborative science platform where hypotheses can be posted, discussed, challenged and developed in the open. Livestream recap ↓🧵

10,634 Aufrufe

Vitalik showed off his sample of 's first longevity product VD001 - a natural high dose spermidine supplement approved by the Thai FDA.

Vitalik showed off his sample of 's first longevity product VD001 - a natural high dose spermidine supplement approved by the Thai FDA.

34,181 Aufrufe

🔗 Try BIOS here: 🔗 @arXiv paper, "Rethinking the AI Scientist": 🔗 Learn more about the vision for BIOS and the Bio ecosystem:

🔗 Try BIOS here: 🔗 @arXiv paper, "Rethinking the AI Scientist": 🔗 Learn more about the vision for BIOS and the Bio ecosystem:

15,490 Aufrufe

The smallest bonds shape the largest futures

The smallest bonds shape the largest futures

17,910 Aufrufe

We're still at the embryonic stage of autonomous science It's about to get so much cooler

We're still at the embryonic stage of autonomous science It's about to get so much cooler

17,728 Aufrufe

"AI bot that's doing protein folding and literally coming up with cures, doing personalized medicine for cancer patients... you could have the equivalent of like a GoFundMe, but on the blockchain, for people to basically be able to pay an AI bot to cure their cancer." BIOS is built for this. It generates discoveries. Bio Launchpad funds them. Biofy brings validated treatments to patients. Discovery -> funding -> product One system.

"AI bot that's doing protein folding and literally coming up with cures, doing personalized medicine for cancer patients... you could have the equivalent of like a GoFundMe, but on the blockchain, for people to basically be able to pay an AI bot to cure their cancer." BIOS is built for this. It generates discoveries. Bio Launchpad funds them. Biofy brings validated treatments to patients. Discovery -> funding -> product One system.

11,129 Aufrufe

Videos